(27 days)
No
The description details standard pulse oximetry technology based on light absorption and does not mention any AI or ML components.
No
The device is a non-invasive monitoring device that measures oxygen saturation and pulse rate, it does not provide therapy.
Yes
The device is indicated for "continuous noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO₂) and pulse rate," which are measurements used by healthcare professionals to diagnose and monitor patient conditions.
No
The device description explicitly details physical hardware components including a portable stand-alone device with a screen, electronic hardware, connecting cable, and oximetry sensor(s). It also mentions power sources (AC and battery) and physical dimensions and weight.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The Dolphin Medical Stand-Alone Pulse Oximeter measures functional oxygen saturation of arterial hemoglobin (SpO₂) and pulse rate noninvasively using a sensor placed on the patient. It does not analyze samples taken from the body.
- Intended Use: The intended use describes continuous noninvasive monitoring, which is consistent with a physiological monitoring device, not an IVD.
Therefore, the device described is a physiological monitoring device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Dolphin Medical Stand-Alone Pulse Oximeter Model 2100 and Accessories are indicated for the continuous noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO-) and pulse rate (measured by an SpO- sensor). The Dolphin Medical Pulse Oximeter Model 2100 and Accessories are indicated for use with adult, pediatric, and neonatal patients during both motion and no motion conditions and for patients who are well or poorly perfused in hospital-type facilities and home environments.
Product codes
DQA
Device Description
The Dolphin Medical Pulse Oximeter Model 2100 and Accessories is a portable stand-alone device, connecting cable, and oximetry sensor(s) to noninvasively calculate the functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate for adult, pediatric and neonatal patients.
The monitor consists of a screen that displays the pulse plethysmographic waveform, the pulse rate, SpOz value, the high and low SpO2 and pulse rate alarms, trends and status messages. It contains the electronic hardware and software that receives and calculates the signals from the LEDs within the sensor to determine the functional oxygen saturation of arterial hemoglobin (SpO-) and pulse rate, and provide for the connection to the connecting cable.
The Dolphin Medical Pulse Oximeter Model 2100 is available in one configuration as a portable standalone oximeter that is 10 cm / 3.94 inches high, 27.5 cm / 10.83 inches wide, 25 cm / 9.84 inches deep and weighs about 4 kg / 8,8 lbs. The unit is powered either with a voltage input of 100-240 Vac. 50-60 Hz or with a sealed lead-acid battery with an operating time of approximately 4 hours based upon 2 Ampere hour battery (200mA OEM Module) and a charge time of about 4,5 hours to 80% capacity.
The extension cable connects between the monitor and oximetry sensor(s) and transfers LED drive power and the calibration drive to the oximetry sensor from the monitor receives the detector signal from the oximetry sensor.
The extension cable is available in one configuration and is approximately 8 feet / 2.44m in length, and the sensor(s) are approximately 18 inches / 45.72 cm in lenath.
The sensor(s) measure light absorption of blood from two light emitting diodes (LED's). Oxygen saturated blood absorbs light differently as compared to unsaturated blood. The amount of light absorbed by the blood is used to calculate the ratio of oxygenated hemoglobin to total hemoglobin in arterial blood,
The oximetry sensor is available in either a disposable configuration, and with one configuration for the extension cable (8 feet).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
adult, pediatric, and neonatal patients
Intended User / Care Setting
hospital-type facilities and home environments
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Additional performance validation testing has been performed for the 560 neonatal disposable sensor and has been included in this submission.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
K002036, #K012533, #K012626, and #K020075
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2700 Oximeter.
(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows a series of handwritten characters and numbers. The characters "K" and "o" are written together, followed by the numbers 2, 1, 9, 5, and 9. The handwriting style appears somewhat rough or stylized, giving the impression of a casual or informal note.
510(K) SUMMARY OF SAFETY AND EFFECTIVENESS
Dolphin Medical 2100 Pulse Oximeter and Accessories 7/11/02
Submitter Company
Dolphin Medical - FL 13801 McCormick Dr Tampa, FL 33626
Contact: Jon Werner Phone: 813-818-7488 Fax: 813-818-7488
Sponsor Company
Dolphin Medical, Inc. 12525 Chadron Avenue Hawthorne, CA 90250
Contact: Tammy Conway Phone: 310-349-2308 Fax: 310-978-1816
Manufacturing Facility
Opto Sensors (M) Sdn. Bhd. No. 6 Jalan Angkasa Mas 1 Tebrau Industrial Estate II 81100 Johor Bahru. Malaysia
Common, Classification & Proprietary Names
Common Name: Oximeter Oximeter Class II - 21 CFR 870.2700 - 74 DQA Classification Name: Proprietary Name: Dolphin Medical Stand-Alone Pulse Oximeter, Model No. 2100 and Accessories.
Intended Use
The Dolphin Medical Stand-Alone Pulse Oximeter Model 2100 and Accessories are indicated for the continuous noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO-) and pulse rate (measured by an SpO- sensor). The Dolphin Medical Pulse Oximeter Model 2100 and Accessories are indicated for use with adult, pediatric, and neonatal patients during both motion and no motion conditions and for patients who are well or poorly perfused in hospital-type facilities and home environments.
Predicate Device
The Dolphin Medical Pulse Oximeter and Accessories is substantially equivalent to the following currently marketed device(s):
- Dolphin Medical Stand-Alone Pulse Oximeter, Model No. 2100 and Accessories #K002036, . #K012533, #K012626, and #K020075.
The Dolphin Medical Pulse Oximeter Model 2100 and Accessories is a portable stand-alone device, connecting cable, and oximetry sensor(s) to noninvasively calculate the functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate for adult, pediatric and neonatal patients.
1
The monitor consists of a screen that displays the pulse plethysmographic waveform, the pulse rate, SpOz value, the high and low SpO2 and pulse rate alarms, trends and status messages. It contains the electronic hardware and software that receives and calculates the signals from the LEDs within the sensor to determine the functional oxygen saturation of arterial hemoglobin (SpO-) and pulse rate, and provide for the connection to the connecting cable.
The Dolphin Medical Pulse Oximeter Model 2100 is available in one configuration as a portable standalone oximeter that is 10 cm / 3.94 inches high, 27.5 cm / 10.83 inches wide, 25 cm / 9.84 inches deep and weighs about 4 kg / 8,8 lbs. The unit is powered either with a voltage input of 100-240 Vac. 50-60 Hz or with a sealed lead-acid battery with an operating time of approximately 4 hours based upon 2 Ampere hour battery (200mA OEM Module) and a charge time of about 4,5 hours to 80% capacity.
The extension cable connects between the monitor and oximetry sensor(s) and transfers LED drive power and the calibration drive to the oximetry sensor from the monitor receives the detector signal from the oximetry sensor.
The extension cable is available in one configuration and is approximately 8 feet / 2.44m in length, and the sensor(s) are approximately 18 inches / 45.72 cm in lenath.
The sensor(s) measure light absorption of blood from two light emitting diodes (LED's). Oxygen saturated blood absorbs light differently as compared to unsaturated blood. The amount of light absorbed by the blood is used to calculate the ratio of oxygenated hemoglobin to total hemoglobin in arterial blood,
The oximetry sensor is available in either a disposable configuration, and with one configuration for the extension cable (8 feet).
The Dolphin Medical Stand-Alone Pulse Oximeter, Model No. 2100 and Accessories have been designed to comply with the following standards:
-
- CSA C22.2 No. 601.1
-
- IEC 601-1. Part 1 and Amendments 1 and 2
-
- IEC 601-1-1, Part 1
-
- IEC 601-1-2, Part 1
-
- ISO 9919: 1992
-
- EN 865: 1997
-
- FDA Guidance Document for Pulse Oximeters: 9/7/1992
-
- ASTM 1415:1992, and Draft 10.1
-
- UL2601-1: Second Edition, 1997
-
- IEC 60068-2-6
-
- IEC 60068-2-27
-
- IEC 60068-2-64
-
- ISTA Procedure 2A
The Dolphin Medical Stand-Alone Pulse Oximeter, Model No. 2100 and Accessories is substantially equivalent in design concepts, technologies and materials to the Dolphin Medical Stand-Alone Pulse Oximeter Model No. 2100 and Accessories previously reviewed. Additional performance validation testing has been performed for the 560 neonatal disposable sensor and has been included in this submission.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized representation of a human figure in profile, with three overlapping heads suggesting a sense of community and support. The figure is positioned within a circle, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA" is arranged around the upper portion of the circle.
Public Health Service
JUL 1 1 2002
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Jon Werner Ouality Assurance Manager Dolphin Medical, Incorporated Dolphin Medical-FL 13801 McCormick Drive Tampa, Florida 33626
Re: K021959
Trade/Device Name: Dolphin Medical Stand-Alone Pulse Oximeter, Model 2100 Regulation Number: 870.2700 Regulation Name: Oximeter Regulatory Class: II Product Code: DQA Dated: June 12, 2002 Received: June 14, 2002
Dear Mr. Werner:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting vour device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
3
Page 2 - Mr. Werner .
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Timothy W. Ulteig
Timothy K. Ulatowski Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
INDICATIONS FOR INTENDED USE FOR 2100 PULSE OXIMETER
510(k) Number (if known): K021959
Device Name: Dolphin Medical Stand-Alone Pulse Oximeter, Model No. 2100
July 11, 2002
Indications for Use:
The Dolphin Medical Stand-Alone Pulse Oximeter, Model No. 2100 and Accessories are indicated for the continuous noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO₂) and pulse rate (measured by an SpO2 sensor).
Accessories:
Dolphin ONE Disposable Sensors Dolphin ONE 210 Reusable Finger Clip intended for adults / pediatrics greater than 66.14 lbs. (30kg). Dolphin ONE 110 Extension Cable
(PLEASE DO NOT WRITE BELOW THIS LINE - CØNTINUE ON ANOTHER PAGE IF NEEDED)
| Concurrence of CDRH, Office of Device Evaluation (ODE) | |
|---|---|
| (Division Sign-Off) | |
| Division of Cardiovascular, Respiratory, and Neurological Devices | |
| 510(k) Number: | Anesthesia, General Hospital, Infection Control & Dental Devices |
| Prescription Use (Per 21 CFR 801.109) | OR over-the-counter Use |